Dr. Olivier Asselin

Professor

Build a Statement of Purpose

Generate a tailored SOP for Dr. Olivier Asselin. Improve your application with a focused, well-structured draft.

Biography

Olivier Asselin is a professor at the Université de Montréal, focusing on the intersection of mobile platforms, augmented reality, and contemporary art within the context of media arts and cinema. He leads research initiatives in the interuniversity research group Mediatopias, exploring how mobile technologies shape narrative forms in physical spaces, emphasizing the integration of real-time mapping systems and augmented reality applications. In addition, Asselin is involved in the development of interactive fiction within augmented cinema, integrating advanced technologies to create immersive experiences. His research also includes revisiting theoretical frameworks surrounding storytelling, space, and media practices in relation to public institutions. Asselin collaborates with various interdisciplinary research groups, such as Menlo Park and Dômes, at the Institut Arts, cultures et technologies, striving to combine technology with artistic expression. His work in scriptwriting and film direction further enriches his contributions to narrative techniques in visual media.

Research Interests

Experience

Professor

2000-01-01 — Present

Université de Montréal • Montréal, QC

Full Professor in the Department of Art History, Cinema and Media Arts, supervising graduate theses and engaging in research-creation projects.

Requirements for Université de Montréal

Doctorate Program
Requirements
GPA Requirement
Required:3.3
TOEFL
Listening
Required:20
Reading
Required:20
Writing
Required:20
Speaking
Required:20
Total
Required:90
Prerequisites
MSc in Pharmacology or equivalent Research supervisor confirmation
Application Checklist
  • Transcripts
  • Birth certificate
  • Curriculum Vitae
  • Proof of French proficiency (B2/C1)
Specialization Notes

Department of Pharmacology and Physiology - Research intensive with options in Neuropharmacology and Pharmacogenomics.